[Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].


Journal

Zhongguo fei ai za zhi = Chinese journal of lung cancer
ISSN: 1999-6187
Titre abrégé: Zhongguo Fei Ai Za Zhi
Pays: China
ID NLM: 101126433

Informations de publication

Date de publication:
20 Jun 2020
Historique:
entrez: 11 6 2020
pubmed: 11 6 2020
medline: 7 4 2021
Statut: ppublish

Résumé

Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year survival rate is 80%, while the 5-year survival rates remaines at around 50% mainly due to bronchiolitis obliterans syndrome (BOS). BOS is regarded as a fibrosing process in the small airways leading to irreversible airway obstruction. A lot of factors are involved in the development of BOS, such as Ischemia/reperfusion injury, infections, oxidative stress, and acute rejection, etc. Studies have shown that early diagnosis of BOS may improve outcome. It is valuable for the long-term survival of lung transplantation to find out several predictors for the BOS. This article reviews the current state of knowledge on predictors for BOS. 【中文题目:肺移植术后闭塞性细支气管炎综合征预测标记物研究进展】 【中文摘要:肺移植是治疗终末期肺病的有效方法。目前,肺移植术后1年生存率已达到80%,由于闭塞性细支气管炎综合症(bronchiolitis obliterans syndrome, BOS)的发生,5年生存率维持在50%左右。BOS是一个纤维化的过程,最终导致不可逆的气道闭塞。缺血-再灌注损伤、感染、氧化应激以及急性排斥反应等多个因素参与了BOS的发生。研究证实BOS的早期诊断与预后良好相关。因此,寻找灵敏、特异的BOS预测标记物对于提高肺移植患者长期生存具有重要的科学和临床意义。本文就与BOS发生发展相关的免疫调节细胞、分泌性蛋白质、细胞膜蛋白等指标的变化在BOS早期诊断中的作用进行综述。】 【中文关键词:肺移植;闭塞性细支气管炎综合症;预测标记物】.

Autres résumés

Type: Publisher (chi)
【中文题目:肺移植术后闭塞性细支气管炎综合征预测标记物研究进展】 【中文摘要:肺移植是治疗终末期肺病的有效方法。目前,肺移植术后1年生存率已达到80%,由于闭塞性细支气管炎综合症(bronchiolitis obliterans syndrome, BOS)的发生,5年生存率维持在50%左右。BOS是一个纤维化的过程,最终导致不可逆的气道闭塞。缺血-再灌注损伤、感染、氧化应激以及急性排斥反应等多个因素参与了BOS的发生。研究证实BOS的早期诊断与预后良好相关。因此,寻找灵敏、特异的BOS预测标记物对于提高肺移植患者长期生存具有重要的科学和临床意义。本文就与BOS发生发展相关的免疫调节细胞、分泌性蛋白质、细胞膜蛋白等指标的变化在BOS早期诊断中的作用进行综述。】 【中文关键词:肺移植;闭塞性细支气管炎综合症;预测标记物】.

Identifiants

pubmed: 32517455
doi: 10.3779/j.issn.1009-3419.2020.101.03
pmc: PMC7309540
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

chi

Sous-ensembles de citation

IM

Pagination

496-502

Références

Am J Respir Crit Care Med. 2014 Aug 1;190(3):274-81
pubmed: 25003824
Respirology. 2013 Apr;18(3):397-411
pubmed: 23316733
Proc Am Thorac Soc. 2009 Jan 15;6(1):108-21
pubmed: 19131536
J Immunol. 1996 Nov 1;157(9):4194-202
pubmed: 8892657
Transplantation. 2010 Sep 15;90(5):540-6
pubmed: 20628341
Transplantation. 2011 Jul 27;92(2):155-62
pubmed: 21701423
Am J Transplant. 2016 Aug;16(8):2342-51
pubmed: 26887344
J Heart Lung Transplant. 2018 Jun;37(6):770-781
pubmed: 29571601
J Heart Lung Transplant. 2009 May;28(5):468-74
pubmed: 19416775
Eur Rev Med Pharmacol Sci. 2013 Nov;17(22):3073-7
pubmed: 24302189
Am J Pathol. 2011 Sep;179(3):1287-300
pubmed: 21763265
J Immunol. 2009 Apr 1;182(7):4423-31
pubmed: 19299743
Transpl Immunol. 2008 Jan;18(3):260-3
pubmed: 18047935
Semin Immunopathol. 2011 Mar;33(2):117-27
pubmed: 21424593
Semin Respir Crit Care Med. 2010 Apr;31(2):189-207
pubmed: 20354932
Transplantation. 2013 May 15;95(9):1167-72
pubmed: 23425818
Transplantation. 2006 Sep 15;82(5):709-11
pubmed: 16969297
Pediatr Transplant. 2010 Nov;14(7):903-8
pubmed: 20667031
Semin Respir Crit Care Med. 2013 Jun;34(3):336-51
pubmed: 23821508
Am J Transplant. 2005 Jun;5(6):1548-52
pubmed: 15888067
J Heart Lung Transplant. 2001 Nov;20(11):1144-51
pubmed: 11704473
J Heart Lung Transplant. 2012 Oct;31(10):1073-86
pubmed: 22975097
PLoS One. 2014 Jul 28;9(7):e103643
pubmed: 25068264
Am J Transplant. 2013 Mar;13(3):552-61
pubmed: 23356456
Eur Respir J. 1998 Jul;12(1):82-8
pubmed: 9701419
Eur Respir J. 1999 Nov;14(5):1123-30
pubmed: 10596701
Am J Respir Crit Care Med. 2008 Oct 1;178(7):765-73
pubmed: 18617642
Transplantation. 2012 Sep 27;94(6):652-8
pubmed: 22902791
Sarcoidosis Vasc Diffuse Lung Dis. 2013 Mar;30(1):43-51
pubmed: 24003534
J Heart Lung Transplant. 2008 Oct;27(10):1172-5
pubmed: 18926413
J Leukoc Biol. 2010 Jan;87(1):69-77
pubmed: 19801498
Am J Transplant. 2010 Mar;10(3):628-36
pubmed: 20055806
J Heart Lung Transplant. 2010 Jul;29(7):800-7
pubmed: 20417130
J Heart Lung Transplant. 2011 Dec;30(12):1374-80
pubmed: 21871820
Cell Signal. 2010 Nov;22(11):1615-25
pubmed: 20466059
Am J Transplant. 2016 Feb;16(2):640-9
pubmed: 26461171
Thorax. 2000 Jan;55(1):53-9
pubmed: 10607802
Chron Respir Dis. 2012 May;9(2):131-45
pubmed: 22368267
Sci Rep. 2016 May 24;6:26274
pubmed: 27215188
PLoS One. 2014 May 15;9(5):e97214
pubmed: 24831685
Transplantation. 2002 Apr 27;73(8):1264-9
pubmed: 11981419
Am J Respir Crit Care Med. 2011 Apr 15;183(8):1062-70
pubmed: 21169468
Transplantation. 2017 Oct;101(10):2461-2468
pubmed: 27941431
Chest. 2011 Aug;140(2):502-508
pubmed: 21813529
Eur Respir J. 2005 Mar;25(3):494-501
pubmed: 15738294
J Heart Lung Transplant. 2002 Jul;21(7):721-30
pubmed: 12100898
Am J Transplant. 2007 Jul;7(7):1856-61
pubmed: 17524078
Clin Transplant. 2017 Mar;31(3):
pubmed: 28008659
J Heart Lung Transplant. 2014 Feb;33(2):127-33
pubmed: 24374027
Transplantation. 2015 Jan;99(1):86-93
pubmed: 25050473
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1422-7
pubmed: 21078427
J Proteome Res. 2017 Apr 7;16(4):1669-1682
pubmed: 28245130
Surg Today. 2012 Feb;42(3):250-8
pubmed: 22173646
J Thorac Cardiovasc Surg. 2014 Jul;148(1):273-81
pubmed: 24685381
Respir Med. 2015 Sep;109(9):1224-9
pubmed: 26224473
Semin Immunopathol. 2011 Mar;33(2):135-56
pubmed: 21271250
Transplantation. 2006 Dec 27;82(12):1596-601
pubmed: 17198242
Eur J Cell Biol. 2012 Nov-Dec;91(11-12):889-95
pubmed: 22939226
Transpl Immunol. 2017 Jun;42:1-4
pubmed: 28457921
Clin Exp Immunol. 2013 Jul;173(1):150-60
pubmed: 23607447
J Heart Lung Transplant. 2006 Apr;25(4):416-9
pubmed: 16563971
Clin Transplant. 2015 Mar;29(3):179-84
pubmed: 25533723
Transpl Immunol. 2002 Nov;10(4):303-10
pubmed: 12507402
Transplantation. 2015 Sep;99(9):1946-52
pubmed: 25651312
Front Immunol. 2018 Jan 11;8:1841
pubmed: 29375549
Clin Exp Immunol. 2008 Nov;154(2):202-8
pubmed: 18785972

Auteurs

Sijia Yang (S)

The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.

Abudumailamu Abuduwufuer (A)

The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.

Wang Lv (W)

The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.

Feichao Bao (F)

The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.

Jian Hu (J)

The First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH